A detailed history of Schonfeld Strategic Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 29,433 shares of MRK stock, worth $2.87 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,433
Previous 132,668 77.81%
Holding current value
$2.87 Million
Previous $16.4 Million 79.65%
% of portfolio
0.02%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $11.5 Million - $13.3 Million
-103,235 Reduced 77.81%
29,433 $3.34 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $8.19 Million - $8.8 Million
66,180 Added 99.54%
132,668 $16.4 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $6.89 Million - $8.02 Million
60,806 Added 1070.15%
66,488 $8.77 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $6.9 Million - $7.51 Million
-68,868 Reduced 92.38%
5,682 $619,000
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $2.36 Million - $2.62 Million
-22,903 Reduced 23.5%
74,550 $7.67 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $2.47 Million - $2.69 Million
22,740 Added 30.44%
97,453 $11.2 Million
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $4.08 Million - $4.55 Million
39,614 Added 112.86%
74,713 $7.95 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $2.89 Million - $3.7 Million
-33,007 Reduced 48.46%
35,099 $3.89 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $1.69 Million - $1.89 Million
19,946 Added 41.42%
68,106 $5.87 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $3.05 Million - $3.46 Million
-36,542 Reduced 43.14%
48,160 $4.39 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $5.83 Million - $6.53 Million
79,302 Added 1468.56%
84,702 $6.95 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $5.08 Million - $6.36 Million
-70,261 Reduced 92.86%
5,400 $414,000
Q3 2021

Nov 16, 2021

BUY
$71.68 - $78.83 $4.71 Million - $5.18 Million
65,761 Added 664.25%
75,661 $5.68 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $696,069 - $769,923
9,900 New
9,900 $770,000
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $9.54 Million - $11.2 Million
-138,546 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $2.55 Million - $2.83 Million
35,572 Added 34.54%
138,546 $11.3 Million
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $3.57 Million - $4.05 Million
48,825 Added 90.17%
102,974 $9,000
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $1.34 Million - $1.53 Million
19,048 Added 54.27%
54,149 $4.19 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $5.33 Million - $7.38 Million
-84,045 Reduced 70.54%
35,101 $2.7 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $310,009 - $349,809
3,996 Added 3.47%
119,146 $10.8 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $2.53 Million - $2.76 Million
-33,295 Reduced 22.43%
115,150 $9.69 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $1.95 Million - $2.28 Million
-27,955 Reduced 15.85%
148,445 $12.4 Million
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $2.36 Million - $2.69 Million
33,900 Added 23.79%
176,400 $14.7 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $9.28 Million - $10.8 Million
-142,259 Reduced 49.96%
142,500 $10.9 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $789,776 - $928,729
13,690 Added 5.05%
284,759 $20.2 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $13 Million - $15.3 Million
255,933 Added 1690.89%
271,069 $16.5 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $771,330 - $896,505
15,136 New
15,136 $825,000
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $10.2 Million - $12.2 Million
-197,228 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $11.6 Million - $12.5 Million
197,228
197,228 $12.6 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.